Related Experiment Video
Updated: Aug 11, 2026

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Hansenula anomala infection in a neonate
A R Wong1, H Ibrahim, H Van Rostenberghe
1Department of Paediatrics, School of Medical Sciences, University Sains Malaysia, Kelantan. rahim@kck.usm.my
Abstract:
We present an unusual neonatal fungal infection, Hansenula anomala in a very low birthweight infant who underwent abdominal surgery for an omphalocele. Despite treatment with adequate doses of amphotericin B, the yeast continued to grow from the blood culture, and was only eradicated with the use of oral ketoconazole.
Insights
A rare Hansenula anomala fungal infection occurred in a premature infant after surgery. Standard amphotericin B treatment failed, but oral ketoconazole successfully eradicated the yeast.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Mycology
Background:
- Neonatal fungal infections pose significant risks, especially in very low birthweight infants.
- Omphalocele repair surgery can increase susceptibility to infections in neonates.
Observation:
- A very low birthweight infant developed an unusual fungal infection caused by Hansenula anomala following abdominal surgery.
- The infant presented with persistent fungemia despite initial antifungal therapy.
Findings:
- Standard treatment with amphotericin B was ineffective in eradicating Hansenula anomala.
- Oral ketoconazole proved successful in clearing the yeast from blood cultures.
Implications:
- This case highlights the potential for unusual fungal pathogens in neonatal intensive care units.
- Alternative or combination antifungal strategies may be necessary for refractory neonatal fungal infections.
- Early identification and tailored treatment are crucial for managing invasive fungal infections in vulnerable neonates.
Related Concept Videos
Neurulation
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Development of the Oral Microbiota
Cytomegalovirus Disease
Cryptococcal Meningitis
Amebiasis

